industry & reform
Reducing sedative use
Exploring
the RedUSe
intervention
in aged care.
By Juanita
Westbury
W
hen our intervention, RedUSe
(Reducing Use of Sedatives),
was delivered to 150 aged care
homes across Australia from 2014 to 2016, 1
we often heard staff say that when residents
came off sedating medication they became
more engaged and less confused. For many,
reducing the drugs made little difference to
their agitation level or other behaviours. Staff
also told us they felt a sense of achievement
when they managed an agitated or anxious
resident without resorting to medication.
It is important to acknowledge that some
residents do require psychiatric medication
with sedating properties (i.e. antipsychotics,
benzodiazepines, sedating antidepressants)
if they have mental illness such as bipolar
disorder, schizophrenia, severe anxiety states
and major depression. Further, some people
with dementia experience very high levels
of distress, hallucinations and/or pose a risk
of harm to themselves or others. Prescribing
antipsychotics to these residents is justified
provided their effectiveness and adverse
effects are closely monitored and the lowest
effective dose is taken for a time-limited
period (usually three months). 2
However, when these medications are
given to older people with less serious
symptoms such as calling out, agitation
and wandering, the risks associated with
use often outweigh any benefit. To give an
example, about one in five residents with
dementia experiencing agitation will benefit
from taking antipsychotics, yet taking these
medications increases the risk of stroke,
pneumonia, death from all causes, cardiac
problems, falls, tremor and confusion. 2
22 | nursingreview.com.au
My own qualitative research, and that
of researchers overseas, has found that
care staff will often request psychotropic
medication from prescribers with the aim of
‘providing comfort’ or ‘to calm’ residents. 3
Most staff don’t want to ‘dope up residents’
for their own convenience. Many staff and
health practitioners also have a strong belief
in medication, trusting that these drugs are
much more effective than the evidence
suggests. When we gave staff a psychiatric
drug knowledge quiz, we found that most
care staff and health practitioners were
unaware of their adverse effects. 4 Few
could name a guideline they referred to
when prescribing or administering these
medications. There is also marked resistance
to take residents off sedating medication
for fear that behaviours will escalate. Yet,
withdrawal studies suggest that most people
with less severe symptoms can be taken off
these medications successfully with minimal
impact on behaviour. 5
What does the RedUSe intervention
involve? It’s a program lasting six months
involving awareness raising, education
and sedative review. To raise awareness
of sedative medication use, we audited
each home and then compared their use
to others. One large Queensland home
assured me they didn’t have a problem, only
to find that over a third of residents were
taking antipsychotics. If you don’t measure
or compare use, it’s difficult to assess if
use is too high. After, the audit results are
provided to staff, along with education on
sedative use by trained pharmacists. These
sessions aimed to promote discussion by
asking if these drugs improved quality of life,
provoking some very spirited debates. Finally,
a structured review process was conducted
where a nurse, pharmacist and GP reviewed
all residents at the home taking sedatives. 1
Over the past few weeks, when bad news
stories about aged care prevail, we found
that most aged care staff want to do the
right thing – as do the operators. When we
approached a large for-profit provider and a
not-for profit religious group in Australia to
be involved in our intervention, they quickly
committed to include 50 of their homes,
leaving us a target of 100 to recruit. The
aged care industry bodies LASA and ACSA
offered to promote RedUSe in their online
magazines. To our surprise (and delight!),
we were inundated by homes wanting to
participate. Over 330 homes across the
country contacted us in the next four weeks
wanting to take part – a powerful indicator
of the willingness of operators and staff to
ensure appropriate sedative use.
RedUSe, funded by the Department
of Health as a Dementia and Aged Care
Service (DACS) fund was provided to 150
homes from 2014 to 2016. Over 2500 aged
care staff attended training sessions, 300
GPs participated in detailing, and over 150
pharmacists were involved in the initiative in
six states and the ACT.
The project made a significant impact.
Overall use of antipsychotics and
benzodiazepines was reduced by 13 and
21 per cent, respectively. Of our total sample,
two-thirds of participant homes reduced
the use of both psychiatric drug classes,
with 142/150 homes recording a reduction
in the use of either class. When residents
taking sedative medications at baseline (over
4000 aged care residents) were tracked
throughout the six-month intervention,
40 per cent had their sedative dose reduced,
with most having their agent totally ceased.
Importantly, 95 per cent of staff ranked the
education provided by the project as very
good/excellent. 6
Unfortunately, the DACS initiatives from
2014 to 2016, including RedUSe, were
not continued, nor are training materials
available for use, although we have been
informed this is planned. 7 Interim economic
modelling has shown that RedUSe is cost-
effective through medication cost reductions
alone. 6 Ideally, with appropriate support,
the project could be delivered through
federally funded community pharmacy as
a series of Quality Use of Medicines (QUM)
strategies, currently administered through
the Pharmacy Guild. The objectives of the
QUM program are to advise members of
the home’s healthcare team on medication
management issues, provide education
to carers and other healthcare providers,
and assist homes to undertake continuous
improvement activities, including ensuring
accreditation standards are met. 8 ■
Dr Juanita Westbury is an aged care
pharmacist.
*References at nursingreview.com.au